Invesco Ltd. 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 4:27 pm Sale | 2025-06-30 | 13G | Collegium Pharmaceutical, Inc. COLL | Invesco Ltd. IVZ | 1,584,871 4.900% | -190,889 (-10.75%) | Filing |
| 2025-02-07 1:21 pm Purchase | 2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Invesco Ltd. IVZ | 1,775,760 5.500% | 1,775,760 (New Position) | Filing |